应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02158 医渡科技
已收盘 07-03 16:08:13
3.850
+0.070
+1.85%
最高
3.930
最低
3.780
成交量
173.67万
今开
3.830
昨收
3.780
日振幅
3.97%
总市值
40.91亿
流通市值
40.91亿
总股本
10.63亿
成交额
670.57万
换手率
0.16%
流通股本
10.63亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
医渡科技(2158.HK)2024财年年度业绩点评报告:FY24经调整EBITDA首次转正 AI医疗大脑YIDUCORE加速迭代
光大证券 · 13:41
医渡科技(2158.HK)2024财年年度业绩点评报告:FY24经调整EBITDA首次转正 AI医疗大脑YIDUCORE加速迭代
医渡科技宫如璟论道夏季达沃斯:加强行业协同,释放AI医疗巨大潜力
中金在线 · 07-01 15:47
医渡科技宫如璟论道夏季达沃斯:加强行业协同,释放AI医疗巨大潜力
医渡科技(2158.HK)2024财年收入8.07亿元、大幅减亏64.8%,附属公司大模型算法通过网
同壁财经 · 07-01 15:42
医渡科技(2158.HK)2024财年收入8.07亿元、大幅减亏64.8%,附属公司大模型算法通过网
医渡科技06月28日主力资金流出27万元 连续3日减仓
自选股智能写手 · 06-28
医渡科技06月28日主力资金流出27万元 连续3日减仓
一图看懂医渡科技(02158)2024财年业绩
智通财经 · 06-28
一图看懂医渡科技(02158)2024财年业绩
医渡科技(02158)2024财年:现有业务经调整EBITDA首次转正
智通财经 · 06-28
医渡科技(02158)2024财年:现有业务经调整EBITDA首次转正
港股概念追踪 |为医生节省大量的时间 中金看好AI对医疗行业生产率提升将较大(附概念股)
智通财经 · 06-28
港股概念追踪 |为医生节省大量的时间 中金看好AI对医疗行业生产率提升将较大(附概念股)
医渡科技(02158)授出合共689.56万股奖励股份
智通财经网 · 06-27
医渡科技(02158)授出合共689.56万股奖励股份
医渡科技06月27日遭主力抛售84万元 环比增加189.66%
自选股智能写手 · 06-27
医渡科技06月27日遭主力抛售84万元 环比增加189.66%
【港股通】医渡科技(02158)曾跌超3.6% 年度亏损1.95亿元人民币
金吾财讯 · 06-27
【港股通】医渡科技(02158)曾跌超3.6% 年度亏损1.95亿元人民币
医渡科技发布年度业绩 毛利3.39亿元同比增加23.6%
新浪港股 · 06-27
医渡科技发布年度业绩 毛利3.39亿元同比增加23.6%
医渡科技(02158)发布年度业绩 毛利3.39亿元 同比增加23.6% 毛利率升至42.1%创历史新高
智通财经 · 06-27
医渡科技(02158)发布年度业绩 毛利3.39亿元 同比增加23.6% 毛利率升至42.1%创历史新高
《业绩》医渡科技(02158.HK)年度经调整净亏损收窄至1.58亿人民币
阿斯达克财经 · 06-27
《业绩》医渡科技(02158.HK)年度经调整净亏损收窄至1.58亿人民币
医渡科技(02158)2024财年大幅减亏近65% 毛利率创历史新高
智通财经 · 06-27
医渡科技(02158)2024财年大幅减亏近65% 毛利率创历史新高
医渡科技(02158)2024财年业绩:毛利率创历史新高 大模型加速落地
智通财经 · 06-27
医渡科技(02158)2024财年业绩:毛利率创历史新高 大模型加速落地
医渡科技:2024财年年度亏损收窄至2.21亿元,同比减亏65%
界面 · 06-27
医渡科技:2024财年年度亏损收窄至2.21亿元,同比减亏65%
【港股通】医渡科技(02158)年度亏损收窄至1.95亿元人民币 不派末期股息
金吾资讯 · 06-27
【港股通】医渡科技(02158)年度亏损收窄至1.95亿元人民币 不派末期股息
医渡科技宫如璟:企业要一边接受挑战,一边要为未来去布局科技技术
金融界 · 06-25
医渡科技宫如璟:企业要一边接受挑战,一边要为未来去布局科技技术
医渡科技董事长宫如璟:医疗AI的商业化很艰难,但是它的价值是毋庸置疑的
睿见Economy · 06-25
医渡科技董事长宫如璟:医疗AI的商业化很艰难,但是它的价值是毋庸置疑的
港股概念追踪 |华为HDC大会召开在即 鸿蒙生态链受关注(附概念股)
智通财经 · 06-20
港股概念追踪 |华为HDC大会召开在即 鸿蒙生态链受关注(附概念股)
公司概况
公司名称:
医渡科技
所属市场:
SEHK
上市日期:
--
主营业务:
医渡科技有限公司是一家主要提供医疗大数据解决方案的中国投资控股公司。该公司通过三个分部运营。大数据平台和解决方案分部主要由大数据平台产品和为客户提供的其他解决方案组成。生命科学解决方案分部负责向制药、生物技术和医疗设备等公司提供分析驱动型临床开发、基于真实世界证据 (RWE)的研究以及数字化营销解决方案。健康管理平台和服务分部主要运营研究驱动型个人健康管理平台,以及向保险公司和代理机构提供保险科技和疾病管理解决方案。该公司主要数据智能基础设施为YiduCore。
发行价格:
--
{"stockData":{"symbol":"02158","market":"HK","secType":"STK","nameCN":"医渡科技","latestPrice":3.85,"timestamp":1719994093014,"preClose":3.78,"halted":0,"volume":1736700,"delay":0,"floatShares":1062556401,"shares":1062556401,"eps":-0.19815157,"marketStatus":"已收盘","marketStatusCode":5,"change":0.07,"latestTime":"07-03 16:08:13","open":3.83,"high":3.93,"low":3.78,"amount":6705730,"amplitude":0.039683,"askPrice":3.88,"askSize":19000,"bidPrice":3.85,"bidSize":47200,"shortable":3,"etf":0,"ttmEps":-0.19815157224105875,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1720056600000},"adr":0,"listingDate":1610640000000,"adjPreClose":3.78,"openAndCloseTimeList":[[1719970200000,1719979200000],[1719982800000,1719993600000]],"volumeRatio":0.953732,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02158/wiki","defaultTab":"wiki","newsList":[{"id":"2448126399","title":"医渡科技(2158.HK)2024财年年度业绩点评报告:FY24经调整EBITDA首次转正 AI医疗大脑YIDUCORE加速迭代","url":"https://stock-news.laohu8.com/highlight/detail?id=2448126399","media":"光大证券","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448126399?lang=zh_cn&edition=full","pubTime":"2024-07-03 13:41","pubTimestamp":1719985300,"startTime":"0","endTime":"0","summary":"事件:公司FY2024收入8.07亿元人民币,同比上升0.3%。盈利能力方面,毛利率42.1%,同比上升8.0pct;剔除非现金科目+非运营科目中的利息支出+自研大模型投入+所得税费用后的经调整EBITDA 3,100万元人民币,首次实现全年盈利;归母净亏损由去年同期的6.28亿元人民币大幅收窄至1.95亿元人民币。大数据平台解决方案板块收入同比回升,AI医疗大脑YiduCore加速迭代:FY2024 BDPS板块收入3.14亿元人民币,同比上升41.4%;毛利率43.7%,同比上升0.5pct。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703134144956ba540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703134144956ba540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02158","BK1189","BK1518"],"gpt_icon":0},{"id":"2448968837","title":"医渡科技宫如璟论道夏季达沃斯:加强行业协同,释放AI医疗巨大潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2448968837","media":"中金在线","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448968837?lang=zh_cn&edition=full","pubTime":"2024-07-01 15:47","pubTimestamp":1719820038,"startTime":"0","endTime":"0","summary":"今年是医渡科技成立的第十年,也是宫如璟女士投身医疗事业的第十年。截至2024年3月31日,医渡科技的“AI医疗大脑”YiduCore经授权处理和分析了50亿多份医疗记录,覆盖了超过2500家医院。她呼吁政策制定者、医疗机构、科技企业等各方共同努力,以实现医疗数据的巨大潜力。宫如璟女士指出,建立信任是关键,同时需要提升数据的可操作性,以充分释放数据的力量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407011551009eeb3354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407011551009eeb3354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","BK1518","02158"],"gpt_icon":0},{"id":"2448496883","title":"医渡科技(2158.HK)2024财年收入8.07亿元、大幅减亏64.8%,附属公司大模型算法通过网","url":"https://stock-news.laohu8.com/highlight/detail?id=2448496883","media":"同壁财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448496883?lang=zh_cn&edition=full","pubTime":"2024-07-01 15:42","pubTimestamp":1719819755,"startTime":"0","endTime":"0","summary":"近日, 医渡科技 发布2024财年的年度业绩公告。公告显示,公司2024财年总收入为人民币8.07亿元,其中来自大数据平台和解决方案的收入由上一财年的2.22亿元增加至3.14亿元,同比大增41.4%。经调整净亏损由去年同期的人民币4.49亿元收窄至人民币1.58亿元,较上年同期大幅减亏64.8%,现金流持续优化。中金公司 6月30日发布评级报告称,维持医渡科技“跑赢行业”评级,最高目标价为5.8港元,与此前最高目标价一致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407011550319eeb3263&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407011550319eeb3263&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02158","BK1518"],"gpt_icon":0},{"id":"2446388520","title":"医渡科技06月28日主力资金流出27万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2446388520","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446388520?lang=zh_cn&edition=full","pubTime":"2024-06-28 16:15","pubTimestamp":1719562557,"startTime":"0","endTime":"0","summary":"06月28日, 医渡科技股价跌1.80%,报收3.82元,成交金额748万元,换手率0.18%,振幅3.60%,量比0.61。医渡科技今日主力资金净流出27万元,连续3日净流出,上一交易日主力净流出84万元,今日环比减少67.86%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为52.94%,平均跌幅为2.29%。该股近5个交易日下跌8.41%,主力资金累计净流出152万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入783万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062816162595e1d2ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062816162595e1d2ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02158","BK1189","BK1518"],"gpt_icon":0},{"id":"2446546011","title":"一图看懂医渡科技(02158)2024财年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2446546011","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446546011?lang=zh_cn&edition=full","pubTime":"2024-06-28 11:18","pubTimestamp":1719544689,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,6月28日,中国AI医疗头部企业医渡科技(02158)召开2024财年业绩发布会。公司2024财年总收入为人民币8.07亿元,毛利率从去年同期的34.1%上升至42.1%,提高8个百分点,创下历史新高。经调整净亏损由去年同期的人民币4.49亿元收窄至人民币1.58亿元,较上年同期大幅减亏64.8%,现金流持续优化。报告期内,公司持续投入人工智能技术,特别是自研医疗垂类大语言模型的研发和商业化,以在大模型时代机遇中保持领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1142252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","02158","BK1189"],"gpt_icon":0},{"id":"2446545897","title":"医渡科技(02158)2024财年:现有业务经调整EBITDA首次转正","url":"https://stock-news.laohu8.com/highlight/detail?id=2446545897","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446545897?lang=zh_cn&edition=full","pubTime":"2024-06-28 11:12","pubTimestamp":1719544343,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,6月28日,中国AI医疗头部企业医渡科技召开2024财年业绩发布会,管理层就业绩亮点、发展战略及未来展望进行详细说明。发布会上,公司管理层表示,剔除自研大模型的战略性投入、非现金科目、非运营科目后,现有业务管理口径经调整EBITDA从去年同期的亏损人民币3.27亿由亏转盈,至本财年的首次盈利人民币3110万元。截至2024年3月31日,公司的真实世界研究监管类项目累计8个,处于行业领先水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406281121419f6e33a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406281121419f6e33a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1518","BK1189","02158"],"gpt_icon":0},{"id":"2446451698","title":"港股概念追踪 |为医生节省大量的时间 中金看好AI对医疗行业生产率提升将较大(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2446451698","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446451698?lang=zh_cn&edition=full","pubTime":"2024-06-28 09:09","pubTimestamp":1719536948,"startTime":"0","endTime":"0","summary":"对于医生群体来说,最热门的新技术——AI,有望带回一种古老的医疗实践方式:与病人们进行面对面交谈。DAX Copilot总经理Kenneth Harper表示,现在有高达200多个组织在使用这项技术。未来十年,AI对采矿、医疗、资源加工、信息、租赁和商务服务等行业的生产率提升较大,对批发零售、住宿餐饮、轻工制造等行业的生产率提升较小。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1142167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","07226","159891","HSCEI","HSTECH","BK1518","BK1189","02158","YANG"],"gpt_icon":0},{"id":"2446753419","title":"医渡科技(02158)授出合共689.56万股奖励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2446753419","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446753419?lang=zh_cn&edition=full","pubTime":"2024-06-27 20:21","pubTimestamp":1719490880,"startTime":"0","endTime":"0","summary":"医渡科技(02158)发布公告,于2024年6月27日,该公司根据首次公开发售后股...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_34.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_34.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02158","BK1518","BK1189"],"gpt_icon":0},{"id":"2446300102","title":"医渡科技06月27日遭主力抛售84万元 环比增加189.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446300102","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446300102?lang=zh_cn&edition=full","pubTime":"2024-06-27 16:17","pubTimestamp":1719476222,"startTime":"0","endTime":"0","summary":"06月27日, 医渡科技股价跌4.66%,报收3.89元,成交金额870万元,换手率0.21%,振幅5.15%,量比0.63。医渡科技今日主力资金净流出84万元,上一交易日主力净流出29万元,今日环比增加189.66%。该股近5个交易日下跌6.04%,主力资金累计净流出161万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流入831万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062716174895dd7e27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062716174895dd7e27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02158","BK1518"],"gpt_icon":0},{"id":"2446937055","title":"【港股通】医渡科技(02158)曾跌超3.6% 年度亏损1.95亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2446937055","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446937055?lang=zh_cn&edition=full","pubTime":"2024-06-27 13:32","pubTimestamp":1719466353,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医渡科技(02158)反复走低,低见3.93港元,跌幅为3.68%,截止发稿,仍跌2.21%,报3.99港元,成交额439.64万港元.公司午间公布财年业绩,截至2024年3月31日止财政年度,录得公司拥有人应占亏损1.95亿元(人民币,下同),同比亏损收窄68.96%,每股基本亏损0.19元。不派末期股息。期内,集团收入8.07亿元,同比增长0.3%。详细来看,来自大数据平台和解决方案的收入增长41.4%至3.14亿元;来自生命科学解决方案的收入增长28.1%至3.24亿元;来自健康管理平台和解决方案的收入减少48.7%至1.7亿元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/OWQ4NGY3MGJmOTZjMTUwZjdhOTdjYjQwNjE1MDM0NDE4NQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OWQ4NGY3MGJmOTZjMTUwZjdhOTdjYjQwNjE1MDM0NDE4NQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1939417","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","HSCEI","YANG","BK1189","02158","07226","BK1518"],"gpt_icon":0},{"id":"2446774063","title":"医渡科技发布年度业绩 毛利3.39亿元同比增加23.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446774063","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446774063?lang=zh_cn&edition=full","pubTime":"2024-06-27 13:19","pubTimestamp":1719465584,"startTime":"0","endTime":"0","summary":"医渡科技(02158)发布截至2024年3月31日止年度业绩,该集团期内取得收入8.07亿元(人民币,下同),同比增加0.3%;毛利3.39亿元,同比增加23.6%;经调整净亏损1.58亿元,同比收窄64.8%;每股基本亏损0.19元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-27/doc-incaczkm5438334.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-27/doc-incaczkm5438334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1518","02158","BK1189"],"gpt_icon":0},{"id":"2446537210","title":"医渡科技(02158)发布年度业绩 毛利3.39亿元 同比增加23.6% 毛利率升至42.1%创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2446537210","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446537210?lang=zh_cn&edition=full","pubTime":"2024-06-27 12:34","pubTimestamp":1719462877,"startTime":"0","endTime":"0","summary":"智通财经APP讯,医渡科技 发布截至2024年3月31日止年度业绩,该集团期内取得收入8.07亿元,同比增加0.3%;毛利3.39亿元,同比增加23.6%;经调整净亏损1.58亿元,同比收窄64.8%;每股基本亏损0.19元。报告期间,集团的整体业务保持稳定,毛利率显著提升,亏损较去年同期大幅缩窄,现金流持续优化。报告期间,毛利率从2023财年的34.1%上升至42.1%,提高8.0个百分点,创下历史新高。截至2024年3月31日,YiduCore经授权已处理及分析了超过10亿名患者人次的50亿多份医疗记录。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141399.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","BK1189","02158"],"gpt_icon":0},{"id":"2446374241","title":"《业绩》医渡科技(02158.HK)年度经调整净亏损收窄至1.58亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2446374241","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446374241?lang=zh_cn&edition=full","pubTime":"2024-06-27 12:31","pubTimestamp":1719462660,"startTime":"0","endTime":"0","summary":"医渡科技(02158.HK) 公布截至今年3月底止全年业绩,客户合同收入8.07亿元人民币(下同),按年升0.33%。亏损1.95亿元,上年同期蚀6.28亿元;每股亏损0.19元。不派息。过往派息公布日期派息事项派息内容2023/11/29中期业绩无派息2023/06/30末期业绩无派息 2022/11/25中期业绩无派息 2022/06/24末期业绩无派息 根据非国际财务报告准则,年度经调整净亏损1.58亿元,上年同期亏损4.49亿元。(vc/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-06-26 16:25。)AASTOCKS新闻","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210415113532898_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210415113532898_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1359670/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02158","BK1518","BK1189"],"gpt_icon":0},{"id":"2446988374","title":"医渡科技(02158)2024财年大幅减亏近65% 毛利率创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2446988374","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446988374?lang=zh_cn&edition=full","pubTime":"2024-06-27 12:30","pubTimestamp":1719462600,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,6月27日,中国AI医疗行业头部企业医渡科技披露2024财年业绩。报告期内,医渡科技毛利率显著提高8个百分点至42.1%,创历史新高;经调整净亏损人民币1.58亿元,较上年同期大幅减亏64.8%。其中,大数据平台和解决方案板块期内收入实现人民币约3.14亿元,同比激增41.4%。生命科学解决方案板块实现收入人民币3.24亿元,同比上升28.1%,毛利率提高了14.6个百分点达32.1%,创历史新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","02158","BK1189"],"gpt_icon":0},{"id":"2446374602","title":"医渡科技(02158)2024财年业绩:毛利率创历史新高 大模型加速落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2446374602","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446374602?lang=zh_cn&edition=full","pubTime":"2024-06-27 12:27","pubTimestamp":1719462430,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,6月27日,中国AI医疗行业领导者医渡科技公布2024财年业绩。报告期内,医渡科技实现收入人民币8.07亿元,毛利率从去年同期的34.1%上升至42.1%,提高8个百分点,创下历史新高。2024财年,医渡科技聚焦核心业务,专注于提升内部经营效率和盈利质量。生命科学解决方案板块收入达到人民币3.24亿元,同比增长28.1%,毛利率提高14.6个百分点至32.1%,创历史新高。同时,医渡科技积极、迅速地推动大模型落地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141397.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158","BK1189","BK1518"],"gpt_icon":0},{"id":"2446749573","title":"医渡科技:2024财年年度亏损收窄至2.21亿元,同比减亏65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446749573","media":"界面","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446749573?lang=zh_cn&edition=full","pubTime":"2024-06-27 12:23","pubTimestamp":1719462192,"startTime":"0","endTime":"0","summary":"医渡科技6月27日在港交所公司,截至2024年3月31日止财政年度(“2024财年”),集团的总收入为8.071亿元,毛利率从2023财年的34.1%上升至42.1%,提高8.0个百分点,创下历史新高。年度亏损由2023财年的6.324亿元收窄至报告期间的2.212亿元,同比减亏65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627122312aef6d8b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627122312aef6d8b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","BK1518","02158"],"gpt_icon":0},{"id":"2446374954","title":"【港股通】医渡科技(02158)年度亏损收窄至1.95亿元人民币 不派末期股息","url":"https://stock-news.laohu8.com/highlight/detail?id=2446374954","media":"金吾资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446374954?lang=zh_cn&edition=full","pubTime":"2024-06-27 12:17","pubTimestamp":1719461823,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医渡科技(02158)公布,截至2024年3月31日止财政年度,录得公司拥有人应占亏损1.95亿元(人民币,下同),同比亏损收窄68.96%,每股基本亏损0.19元。不派末期股息。期内,集团收入8.07亿元,同比增长0.3%。详细来看,来自大数据平台和解决方案的收入增长41.4%至3.14亿元;来自生命科学解决方案的收入增长28.1%至3.24亿元;来自健康管理平台和解决方案的收入减少48.7%至1.7亿元。期内,毛利为3.39亿元,同比增长23.65%。整体毛利率为42.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406271217409f6a4f4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406271217409f6a4f4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSCEI","BK1189","HSTECH","07226","02158","BK1518"],"gpt_icon":0},{"id":"2446846187","title":"医渡科技宫如璟:企业要一边接受挑战,一边要为未来去布局科技技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2446846187","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446846187?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:09","pubTimestamp":1719320973,"startTime":"0","endTime":"0","summary":"“2024夏季达沃斯新浪财经之夜.正和岛夜话”6月25日在大连举办。医渡科技董事长兼创始人宫如璟出席并演讲。宫如璟谈到,现在医疗行业面临的挑战还是非常多的,从政策的稳定性到整个A股和港股市场的波动,到整个医疗行业的变化。同时,科技发展,特别是人工智能、材料和生物技术,预计在未来几年会有本质的变化。“一边要接受这些挑战,另外一边也要为未来去布好科技技术的局”,她建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521155595d69de9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521155595d69de9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1518","BK1189","02158"],"gpt_icon":0},{"id":"2446451638","title":"医渡科技董事长宫如璟:医疗AI的商业化很艰难,但是它的价值是毋庸置疑的","url":"https://stock-news.laohu8.com/highlight/detail?id=2446451638","media":"睿见Economy","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446451638?lang=zh_cn&edition=full","pubTime":"2024-06-25 20:49","pubTimestamp":1719319740,"startTime":"0","endTime":"0","summary":"医渡科技董事长兼创始人宫如璟出席并演讲。 谈及医渡科技的重点和优势,宫如璟表示,首先,公司最大的优势是一直非常关注研发,并认为未来三到五年是人工智能发展的重要起点时期。 宫如璟认为,医疗AI的发展相对艰难,因为医疗是一个高政策的行业,面对很多很多的监管。 但是她也指出,尽管医疗AI的商业化很艰难,但是它的价值是毋庸置疑的。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/hy/hyjz/2024-06-25/doc-inazyeaf6906123.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2024-06-25/doc-inazyeaf6906123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["150261","BK1189","BK1518","02158"],"gpt_icon":0},{"id":"2444232132","title":"港股概念追踪 |华为HDC大会召开在即 鸿蒙生态链受关注(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2444232132","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444232132?lang=zh_cn&edition=full","pubTime":"2024-06-20 10:24","pubTimestamp":1718850283,"startTime":"0","endTime":"0","summary":"机构预计华为将在HDC 2024推出HarmonyOS NEXT Beta版系统,正式版本将在2024Q4与Mate 70系列一同推出,届时将不在兼容安卓。 根据财经媒体,鸿蒙原生生态定位华为2024年的“一号工程”。 HarmonyOS NEXT的特点之一是“原生智能”,华为将操作系统层的鸿蒙和模型层的盘古联合起来,共同构建AIOS。中信建投研报表示,华为HDC大会即将召开,盘古大模型5.0与HarmonyOS NEXT鸿蒙星河版将首次同台亮相,或将加速纯血鸿蒙生态的建设与产品落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1137797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","BK1155","BK1526","HSCEI","YANG","BK1189","00354","BK1589","02158","07226","BK1586","BK1518"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0597},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.0574},{"period":"6month","weight":-0.1429},{"period":"1year","weight":-0.3077},{"period":"ytd","weight":-0.253}],"compareEarnings":[{"period":"1week","weight":-0.0168},{"period":"1month","weight":-0.0172},{"period":"3month","weight":0.0624},{"period":"6month","weight":0.0675},{"period":"1year","weight":-0.0796},{"period":"ytd","weight":0.0423}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"医渡科技有限公司是一家主要提供医疗大数据解决方案的中国投资控股公司。该公司通过三个分部运营。大数据平台和解决方案分部主要由大数据平台产品和为客户提供的其他解决方案组成。生命科学解决方案分部负责向制药、生物技术和医疗设备等公司提供分析驱动型临床开发、基于真实世界证据 (RWE)的研究以及数字化营销解决方案。健康管理平台和服务分部主要运营研究驱动型个人健康管理平台,以及向保险公司和代理机构提供保险科技和疾病管理解决方案。该公司主要数据智能基础设施为YiduCore。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.182051},{"month":2,"riseRate":0.5,"avgChangeRate":0.072152},{"month":3,"riseRate":0,"avgChangeRate":-0.145896},{"month":4,"riseRate":0.5,"avgChangeRate":-0.026639},{"month":5,"riseRate":0,"avgChangeRate":-0.077808},{"month":6,"riseRate":0.5,"avgChangeRate":0.082247},{"month":7,"riseRate":0,"avgChangeRate":-0.084082},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.134204},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.187587},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.054814},{"month":11,"riseRate":0.666667,"avgChangeRate":0.113273},{"month":12,"riseRate":0.666667,"avgChangeRate":0.063814}],"exchange":"SEHK","name":"医渡科技","nameEN":"YIDU TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医渡科技,02158,医渡科技股票,医渡科技股票老虎,医渡科技股票老虎国际,医渡科技行情,医渡科技股票行情,医渡科技股价,医渡科技股市,医渡科技股票价格,医渡科技股票交易,医渡科技股票购买,医渡科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}